Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
PACIRA RG (NQ: PCRX)
47.65 USD  -1.50 (-3.05%)
Official Closing Price  /  Updated: 8:10 PM EDT, Jul 21, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 385,661
Open 49.65
Bid (Size) 47.70 (100)
Ask (Size) 59.05 (500)
Prev. Close 49.15
Today's Range 47.50 - 49.80
52wk Range 29.95 - 58.95
Shares Outstanding 40,093,883
Dividend Yield N/A
Performance
YTD
+37.12%
+37.12%
1 Month
+1.60%
+1.60%
3 Month
+5.42%
+5.42%
6 Month
+18.83%
+18.83%
1 Year
+26.59%
+26.59%
Top News
More News
Pacira Pharmaceuticals Appoints Mark I. Froimson, M.D., to Board of Directors
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced the appointment of Mark I. Froimson, M.D. to its board of directors. Dr. Froimson is currently serving as the President of the American... Read More
from GlobeNewswire News Releases
Pacira Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that members of its management team are scheduled to present at the JMP Securities Life Sciences Conference at 3:00 PM ET on Tuesday, June 20,... Read More
from GlobeNewswire News Releases
More News
Read More
Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma
from PR Newswire
Pacira Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
from GlobeNewswire News Releases
Pacira Pharmaceuticals Announces Resignation of James Scibetta
from GlobeNewswire News Releases
Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
from GlobeNewswire News Releases
Pacira Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results
from GlobeNewswire News Releases
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Treat Postsurgical Pain if Given the Option
from GlobeNewswire News Releases
How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma
from PR Newswire
Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and Conference Call
from GlobeNewswire News Releases
Notable Thursday Option Activity: TGT, MCO, PCRX
category Stocks
from Market News Video
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial